Insulin resistance is a major risk factor for developing type 2 diabetes mellitus (T2DM). Epidemiological data suggest that dietary anthocyanins (ACN) are associated with lower insulin resistance (IR) and T2DM risk. The present study assessed the effects of strawberries, a major dietary source of ACN, on acute insulin and glucose responses in individuals with IR. In a randomized 4‐arm crossover study, 23 obese adults consumed beverages containing freeze‐dried strawberry powder (FDS) at 4 levels [0, 10, 20, or 40 g corresponding to ~0 to 368 umol ACN]. The FDS beverages were fiber controlled and served with a standard meal with blood collected before and for 6 h after meal consumption on 4 occasions. Mean 6 h insulin was significantly lowered after consuming the 40 g FDS beverage/meal compared to all other beverages (p<0.05). No differences were observed in 6 h glucose responses, although the magnitude of increase from baseline was significantly lower (~29%) after the 40 g FDS beverage compared to other beverages (p<0.05). In adults with higher fasting insulin and greater IR, significant reductions in peak post meal insulin was apparent with 20 g and 40 g FDS beverages (p<0.05), whereas in those with a lesser degree of IR the 40 g FDS reduced peak post meal insulin. Oxidative stress was not different between groups, whereas IL‐6 was lowest after the 10 g FDS beverage. FDS ACN increased in plasma dose‐dependently reaching peak concentrations between 130 and 189 ± 45 min. These data support the view that strawberries have a role in improving insulin sensitivity in people with insulin resistance. Supported by CA Strawberry Commission, CA Dept of Food and Ag, Sacramento, CA. USA
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.